Pacific Biosciences Of California PE Ratio 2011-2025 | PACB
Current and historical p/e ratio for Pacific Biosciences Of California (PACB) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pacific Biosciences Of California PE ratio as of November 17, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pacific Biosciences Of California PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-17 | 1.57 | 0.00 | |
| 2025-09-30 | 1.28 | $-2.20 | 0.00 |
| 2025-06-30 | 1.24 | $-2.29 | 0.00 |
| 2025-03-31 | 1.18 | $-2.79 | 0.00 |
| 2024-12-31 | 1.83 | $-1.64 | 0.00 |
| 2024-09-30 | 1.70 | $-1.46 | 0.00 |
| 2024-06-30 | 1.37 | $-1.50 | 0.00 |
| 2024-03-31 | 3.75 | $-1.14 | 0.00 |
| 2023-12-31 | 9.81 | $-1.21 | 0.00 |
| 2023-09-30 | 8.35 | $-1.27 | 0.00 |
| 2023-06-30 | 13.30 | $-1.35 | 0.00 |
| 2023-03-31 | 11.58 | $-1.39 | 0.00 |
| 2022-12-31 | 8.18 | $-1.40 | 0.00 |
| 2022-09-30 | 5.81 | $-1.34 | 0.00 |
| 2022-06-30 | 4.42 | $-0.92 | 0.00 |
| 2022-03-31 | 9.10 | $-0.81 | 0.00 |
| 2021-12-31 | 20.46 | $-0.89 | 0.00 |
| 2021-09-30 | 25.55 | $-0.21 | 0.00 |
| 2021-06-30 | 34.97 | $-0.43 | 0.00 |
| 2021-03-31 | 33.31 | $-0.37 | 0.00 |
| 2020-12-31 | 25.94 | $0.09 | 288.22 |
| 2020-09-30 | 9.87 | $-0.28 | 0.00 |
| 2020-06-30 | 3.45 | $-0.33 | 0.00 |
| 2020-03-31 | 3.06 | $-0.34 | 0.00 |
| 2019-12-31 | 5.14 | $-0.55 | 0.00 |
| 2019-09-30 | 5.16 | $-0.76 | 0.00 |
| 2019-06-30 | 6.05 | $-0.76 | 0.00 |
| 2019-03-31 | 7.23 | $-0.77 | 0.00 |
| 2018-12-31 | 7.40 | $-0.77 | 0.00 |
| 2018-09-30 | 5.41 | $-0.74 | 0.00 |
| 2018-06-30 | 3.55 | $-0.74 | 0.00 |
| 2018-03-31 | 2.05 | $-0.83 | 0.00 |
| 2017-12-31 | 2.64 | $-0.89 | 0.00 |
| 2017-09-30 | 5.25 | $-0.92 | 0.00 |
| 2017-06-30 | 3.56 | $-0.92 | 0.00 |
| 2017-03-31 | 5.17 | $-0.87 | 0.00 |
| 2016-12-31 | 3.80 | $-0.84 | 0.00 |
| 2016-09-30 | 8.96 | $-0.65 | 0.00 |
| 2016-06-30 | 7.04 | $-0.44 | 0.00 |
| 2016-03-31 | 8.50 | $-0.39 | 0.00 |
| 2015-12-31 | 13.13 | $-0.43 | 0.00 |
| 2015-09-30 | 3.66 | $-0.67 | 0.00 |
| 2015-06-30 | 5.76 | $-0.82 | 0.00 |
| 2015-03-31 | 5.84 | $-0.93 | 0.00 |
| 2014-12-31 | 7.84 | $-0.94 | 0.00 |
| 2014-09-30 | 4.91 | $-0.94 | 0.00 |
| 2014-06-30 | 6.18 | $-1.12 | 0.00 |
| 2014-03-31 | 5.35 | $-1.18 | 0.00 |
| 2013-12-31 | 5.23 | $-1.27 | 0.00 |
| 2013-09-30 | 5.52 | $-1.40 | 0.00 |
| 2013-06-30 | 2.53 | $-1.50 | 0.00 |
| 2013-03-31 | 2.49 | $-1.57 | 0.00 |
| 2012-12-31 | 1.70 | $-1.70 | 0.00 |
| 2012-09-30 | 1.83 | $-1.73 | 0.00 |
| 2012-06-30 | 2.17 | $-1.86 | 0.00 |
| 2012-03-31 | 3.42 | $-1.88 | 0.00 |
| 2011-12-31 | 2.80 | $-2.04 | 0.00 |
| 2011-09-30 | 3.21 | $-2.59 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.474B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $213.087B | 25.32 |
| Intuitive Surgical (ISRG) | United States | $195.983B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $53.421B | 53.05 |
| Edwards Lifesciences (EW) | United States | $49.175B | 32.97 |
| Alcon (ALC) | Switzerland | $37.787B | 25.54 |
| IQVIA Holdings (IQV) | United States | $36.805B | 20.52 |
| Mettler-Toledo (MTD) | United States | $28.374B | 33.20 |
| STERIS (STE) | Ireland | $25.225B | 26.04 |
| DexCom (DXCM) | United States | $22.812B | 31.45 |
| Waters (WAT) | United States | $22.503B | 29.76 |
| Hologic (HOLX) | United States | $16.490B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.802B | 0.00 |
| Globus Medical (GMED) | United States | $11.194B | 23.49 |
| Penumbra (PEN) | United States | $10.907B | 76.72 |
| Masimo (MASI) | United States | $7.898B | 25.31 |
| Sysmex ADR (SSMXY) | Japan | $6.137B | 19.50 |
| Glaukos (GKOS) | United States | $5.077B | 0.00 |
| Teleflex (TFX) | United States | $4.590B | 7.31 |
| TransMedics (TMDX) | United States | $3.875B | 45.91 |
| Veracyte (VCYT) | United States | $3.105B | 35.39 |
| Alphatec Holdings (ATEC) | United States | $2.952B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.929B | 15.82 |
| Integer Holdings (ITGR) | United States | $2.351B | 11.04 |
| Artivion (AORT) | United States | $2.138B | 98.09 |
| Nihon Kohden (NHNKY) | Japan | $1.794B | 15.66 |
| Elekta AB (EKTAY) | Sweden | $1.692B | 16.39 |
| PROCEPT BioRobotics (PRCT) | United States | $1.625B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.243B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.196B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.087B | 51.77 |
| OPKO Health (OPK) | United States | $0.975B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.932B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.914B | 4.95 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.570B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.524B | 30.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.516B | 10.30 |
| AngioDynamics (ANGO) | United States | $0.491B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.409B | 0.00 |
| RxSight (RXST) | United States | $0.405B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.396B | 10.92 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.65 |
| Semler Scientific (SMLR) | United States | $0.304B | 2.29 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.184B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.182B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.118B | 0.00 |
| Neuronetics (STIM) | United States | $0.113B | 0.00 |
| Accuray (ARAY) | United States | $0.113B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.091B | 0.00 |
| Hyperfine (HYPR) | United States | $0.088B | 0.00 |
| InspireMD (NSPR) | United States | $0.085B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.07 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |